Over 1600 Total Lots Up For Auction at Four Locations - NJ Cleansweep 05/07, NJ Cleansweep 05/08, CA 05/09, CO 05/12

GE Researches New CT Technologies

by Barbara Kram, Editor | June 26, 2006
WAUKESHA, WI, -- Researchers in Haifa, Israel have captured what GE believes to be the first phantom images from an innovative Computed Tomography (CT) detector. Engineers at GE's Haifa, Israel research center produced a "Spectral CT" image that provides new and different information not captured with existing CT detector technology.

According to Gene Saragnese, global vice president of Molecular Imaging & CT at GE Healthcare, this technology may allow CT to see beyond shades of gray through photon counting that could facilitate the separation of materials in stationary and moving objects such as calcium and iodine in coronary arteries. "This advanced research technology, in addition, has the potential to achieve significantly improved spatial resolution the low X-ray dose associated with photon level detection," said Saragnese.

This new detector, with its innovative approach to imaging, could change the way we look at CT imaging. When dynamically acquiring energy data, the detector counts each individual photon capturing more information on the object with the ability to break down information based on position, type and tissue characteristics.
stats
DOTmed text ad

Your Trusted Source for Sony Medical Displays, Printers & More!

Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.

stats


In mid-summer, a research system is planned to be installed at a clinical partner site in Israel.

About GE Healthcare

GE Healthcare provides transformational medical technologies that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform and treat disease, so their patients can live their lives to the fullest.

GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases, and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention.

Headquartered in the United Kingdom, GE Healthcare is a $15 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 43,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.